Authors

• Sanjiv J. Shah (ORCID: https://orcid.org/0000-0002-5655-8201)
• Brian Lee Claggett (ORCID: https://orcid.org/0000-0002-4215-9218)
• Pardeep S. Jhund (ORCID: https://orcid.org/0000-0003-4306-5317)
• James Lay‐Flurrie
• John J.V. McMurray (ORCID: https://orcid.org/0000-0002-6317-3975)
• Friederike Behmenburg
• Scott David Solomon (ORCID: https://orcid.org/0000-0003-3698-9597)
• Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
• Carolyn S.P. Lam (ORCID: https://orcid.org/0000-0003-1903-0018)
• Adriaan A. Voors
• Maria Borentian
• Akshay S. Desai
• Prabhakar Viswanathan
• Bertram Pitt
• Faı̈ez Zannad (ORCID: https://orcid.org/0000-0001-7456-1570)
• Michele Senni

Institutions

• Northwestern University (US)
• Brigham and Women's Hospital (US)
• University Medical Center Groningen (NL)
• Harvard University (US)
• National University of Singapore (SG)
• University of Groningen (NL)
• University of Michigan (US)
• Ospedale Papa Giovanni XXIII (IT)
• National University Heart Centre Singapore (SG)
• Université Bourgogne Franche-Comté (FR)
• National Heart Centre Singapore (SG)
• French Clinical Research Infrastructure Network (FR)
• University of Milano-Bicocca (IT)
• Bayer (Germany) (DE)
• University of Glasgow (GB)
• Université de Lorraine (FR)

Publication Details

Journal

JAMA Cardiology

Published

2024-09-27

DOI

https://doi.org/10.1001/jamacardio.2024.3782

Citations

11

Primary Topic

Heart Failure Treatment and Management

Type

article

Field-Weighted Citation Impact

4.42

Funders

• Amgen
• Bristol-Myers Squibb
• Eli Lilly and Company
• Pfizer
• AstraZeneca
• Bayer
• Sanofi
• Alnylam Pharmaceuticals
• University of Pittsburgh
• Boston Scientific Corporation
• Cytokinetics
• ReCor Medical
• Impulse Dynamics
• British Heart Foundation
• University of Glasgow
• Novo Nordisk
• Intas Pharmaceuticals